Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.

Item

http://www.wikidata.org/entity/Q50591145

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Chronological changes in basel ...... DMARDs between 2003 and 2012.

@en

Chronological changes in basel ...... DMARDs between 2003 and 2012.

@nl

type

Item

label

Chronological changes in basel ...... DMARDs between 2003 and 2012.

@en

Chronological changes in basel ...... DMARDs between 2003 and 2012.

@nl

prefLabel

Chronological changes in basel ...... DMARDs between 2003 and 2012.

@en

Chronological changes in basel ...... DMARDs between 2003 and 2012.

@nl

P1476

Chronological changes in basel ...... DMARDs between 2003 and 2012.

@en

P2093

Akiko Kobayashi

http://www.w3.org/2001/XMLSchema#string

Atsuo Taniguchi

http://www.w3.org/2001/XMLSchema#string

Ayako Nakajima

http://www.w3.org/2001/XMLSchema#string

Daisuke Hoshi

http://www.w3.org/2001/XMLSchema#string

Eiichi Tanaka

http://www.w3.org/2001/XMLSchema#string

Eisuke Inoue

http://www.w3.org/2001/XMLSchema#string

Eri Sato

http://www.w3.org/2001/XMLSchema#string

Hisashi Yamanaka

http://www.w3.org/2001/XMLSchema#string

Kumi Shidara

http://www.w3.org/2001/XMLSchema#string

Moeko Ochiai

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study.

Ten years with biologics: to whom do data on effectiveness and safety apply?

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study).

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

P304

350-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14397595.2014.958274

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25619283

http://www.w3.org/2001/XMLSchema#string